GR 108359
Latest Information Update: 10 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 24 Aug 1999 Discontinued-I for Bacterial infections in United Kingdom (PO)
- 20 Oct 1994 No-Development-Reported for Bacterial infections in United Kingdom (PO)